1. Title of Derivate Security
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date (Month/Day/Year)
|
3A. Deemed Execution Date, if any (Month/Day/Year)
|
4. Transaction Code
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
|
8. Price of Derivative Security
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
|
11. Nature of Indirect Beneficial Ownership
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expriation Date
|
Title
|
Amount or Number of Shares
|
(*)
|
If the form is filed by more than one reporting person, see Instruction 5(b)(v).
|
(**)
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
(1)
|
Transactions made pursuant to an agreement adopted on June 17, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
|
(2)
|
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.42-99.89, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
|
(3)
|
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.33-100.15, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
|
(4)
|
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.44-100.15, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
|
(5)
|
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.36-100.15, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
|
(6)
|
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.92-100.23, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
|
(7)
|
The price reported in column 4 is the price at which these shares were sold in a single transaction.
|
(8)
|
Options vested and became exercisable in equal 25% installments on each anniversary date of the grant, March 22, 2017, subject to continued service through each applicable vesting date. The options vested in their entirety on March 22, 2021.
|
(9)
|
Options vested and became exercisable in equal 25% installments on each anniversary date of the grant, March 28, 2018, subject to continued service through each applicable vesting date. The options vested in their entirety on March 28, 2022.
|
(10)
|
Options vested and became exercisable in equal 25% installments on each anniversary date of the grant, March 24, 2020, subject to continued service through each applicable vesting date. The options vested in their entirety on March 24, 2024.
|
(11)
|
Options vest and become exercisable in 25% installments on each anniversary date of the grant, March 25, 2022, subject to continued service through each applicable vesting date. The reporting person was granted 13,027 options, of which 3,257 vested on March 25, 2023? 3,257 vested on March 25, 2024? 3,256 vest on March 25, 2025; and 3,257 vest on March 25, 2026.
|
(12)
|
Options vest and become exercisable in 25% installments on each anniversary date of the grant, March 23, 2023, subject to continued service through each applicable vesting date. The reporting person was granted 8,582 options, of which 2,146 vested on March 23, 2024; 2,145 vest on March 23, 2025; 2,146 vest on March 23, 2026; and 2,145 vest on March 23, 2027.
|
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.